Nurse Practitioner, Psychiatric/Mental Health · Frankfort, KY
NPI
1629715768
Since 2022
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
649 Chamberlin Ave
Frankfort, KY, 40601
Phone (216) 468-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$37K
628 services
Medicare patients, 2024
229
Average age 69
Drug cost, 2024
$819K
3,594 prescriptions
Company payments, 2025
$848
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Christina Cotton was code 99214 (office e&m - established), 247 times for 92 patients. In total Christina Cotton billed 628 services in 15 codes, and Medicare paid $37K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 247 | 92 | $68.32 | $17K |
| 96127 Behavioral Health Services | Office | 105 | 55 | $3.13 | $329 |
| 99232 Hospital E&M - Subsequent | Facility | 78 | 42 | $48.49 | $3,782 |
| 99222 Hospital E&M - Initial | Facility | 76 | 74 | $81.40 | $6,187 |
| 90792 Psychotherapy - Nongroup | Office | 30 | 30 | $110.90 | $3,327 |
| 99231 Hospital E&M - Subsequent | Facility | 24 | 19 | $29.96 | $719 |
| 99213 Office E&M - Established | Office | 19 | 13 | $39.03 | $742 |
| 99221 Hospital E&M - Initial | Facility | 18 | 18 | $51.06 | $919 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 12 | $10.40 | $146 |
By year: 2022 $3,457 for 66 services; 2023 $33K for 571 services; 2024 $37K for 628 services.
Medicare prescription drug claims, 2024
In 2024, the drug Christina Cotton prescribed most often to Medicare patients was Clonazepam, with 202 prescriptions and refills. In total Christina Cotton wrote 3,594 Medicare prescriptions that cost $819K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Clonazepam Generic | 202 | 206 | 32 | $1,865 |
| Alprazolam Generic | 193 | 193 | 28 | $642 |
| Trazodone Hcl Generic | 176 | 322 | 39 | $1,472 |
| Sertraline Hcl Generic | 159 | 302 | 38 | $3,352 |
| Lorazepam Generic | 154 | 158 | 22 | $713 |
| Vraylar Cariprazine Hcl | 147 | 167 | 27 | $235K |
| Desvenlafaxine Succinate Er Desvenlafaxine Succinate | 141 | 281 | 34 | $20K |
| Quetiapine Fumarate Generic | 130 | 230 | 28 | $1,256 |
| Buspirone Hcl Generic | 124 | 272 | 34 | $2,251 |
| Aripiprazole Generic | 124 | 206 | 27 | $14K |
| Lamotrigine Generic | 114 | 232 | 31 | $1,544 |
| Hydroxyzine Hcl Generic | 101 | 144 | 27 | $1,337 |
| Risperidone Generic | 90 | 138 | 15 | $1,026 |
| Vilazodone Hcl Generic | 88 | 124 | 17 | $6,837 |
| Bupropion Xl Bupropion Hcl | 86 | 168 | 25 | $1,114 |
Brand drugs: 433 claims; generic drugs: 3,161 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Christina Cotton $848 ($848 in general payments such as food, travel and fees) from 15 companies. The largest payer was ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) with $173.
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $173 |
| Abbvie Inc. ABBV | 12 | $172 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 4 | $90.51 |
| Teva Pharmaceuticals USA, Inc. TEVA | 4 | $81.25 |
| Lundbeck LLC | 3 | $63.26 |
| Janssen Pharmaceuticals, Inc JNJ | 2 | $49.69 |
| Vanda Pharmaceuticals Inc. VNDA | 2 | $42.17 |
| Tris Pharma Inc | 2 | $35.39 |
| E.R. Squibb & Sons, L.L.C. BMY | 1 | $34.84 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $23.54 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.